1. Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy. (January 2014) Authors: Chan, A. C.; Neeson, P.; Leeansyah, E.; Tainton, K.; Quach, H.; Prince, H. M.; Harrison, S. J.; Godfrey, D. I.; Ritchie, D.; Berzins, S. P. Journal: Clinical and experimental immunology Issue: Volume 175:Number 1(2014:Jan.) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0335 Final results of TROG 13.01 SAFRON II: Single vs multi-fraction SABR for pulmonary oligometastases. (August 2021) Authors: Siva, S.; Bressel, M.; Mai, T.; Le, H.; Vinod, S.; de Silva, H.; Macdonald, S.; Skala, M.; Hardcastle, N.; Rezo, A.; Pryor, D.; Gill, S.; Higgs, B.; Wagenfuehr, K.; Montgomery, R.; Awad, R.; Chesson, B.; Eade, T.; Wong, W.; Sasso, G. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The use of ipilimumab in patients with rheumatoid arthritis and metastatic melanoma. (9th February 2016) Authors: Lee, B.; Wong, A.; Kee, D.; Neeson, P.; Shackleton, M.; McArthur, G.; Sandhu, S. Journal: Annals of oncology Issue: Volume 27:Number 6(2016:Jun.) Page Start: 1174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗